Longitudinal fundus imaging and its genome-wide association analysis provide evidence for a human retinal aging clock
- Google Research, United States
- Buck Institute for Research on Aging, United States
- Google Health, United States
- Post Graduate Institute of Medical Education and Research, India
- Zuckerberg San Francisco General Hospital, United States
- University of California, San Francisco, United States
Abstract
Biological age, distinct from an individual's chronological age, has been studied extensively through predictive aging clocks. However, these clocks have limited accuracy in short time-scales. Here we trained deep learning models on fundus images from the EyePACS dataset to predict individuals' chronological age. Our retinal aging clocking, 'eyeAge', predicted chronological age more accurately than other aging clocks (mean absolute error of 2.86 and 3.30 years on quality-filtered data from EyePACS and UK Biobank, respectively). Additionally, eyeAge was independent of blood marker-based measures of biological age, maintaining an all-cause mortality hazard ratio of 1.026 even when adjusted for phenotypic age. The individual-specific nature of eyeAge was reinforced via multiple GWAS hits in the UK Biobank cohort. The top GWAS locus was further validated via knockdown of the fly homolog, Alk, which slowed age-related decline in vision in flies. This study demonstrates the potential utility of a retinal aging clock for studying aging and age-related diseases and quantitatively measuring aging on very short time-scales, opening avenues for quick and actionable evaluation of gero-protective therapeutics.
Data availability
A subset of EyePACS data is freely available online (https://www.kaggle.com/competitions/diabetic-retinopathy-detection/data). To enquire about access to the full EyePACS dataset, researchers should contact Jorge Cuadros (jcuadros@eyepacs.com). Proposals and agreements are assessed internally at EyePACS and may be subject to ethics approvals. The UKB data are available for approved projects (application process detailed at https://www.ukbiobank.ac.uk/enable-your-research/apply-for-access) through the UK Biobank Access Management System (https://www.ukbiobank.ac.uk) . We have deposited the derived data fields and model predictions following UKB policy, which will be available through the UK Biobank Access Management System. Full GWAS summary statistics are available in the Supplementary File. To develop the eyeAge model we used the TensorFlow deep learning framework, available at https://www.tensorflow.org . Code and detailed instructions for both model training and prediction of chronological age from fundus images is open-source and freely available as a minor modification (https://gist.github.com/cmclean/a7e01b916f07955b2693112dcd3edb60) of our previously published repository for fundus model training (https://zenodo.org/record/7154413).
Article and author information
Author details
Funding
NIH (T32AG000266-23)
- Kenneth A Wilson Jr
NIH (R01AG038688)
- Pankaj Kapahi
NIH (AG045835)
- Pankaj Kapahi
Larry L. Hillblom Foundation
- Pankaj Kapahi
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Human subjects: The UK Biobank study was reviewed and approved by the North West Multi-Centre Research Ethics Committee. For the EyePACS study, ethics review and IRB exemption was obtained using Quorum Review IRB (Seattle, WA).
Copyright
© 2023, Ahadi et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,907
- views
-
- 625
- downloads
-
- 17
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Longitudinal fundus imaging and its genome-wide association analysis provide evidence for a human retinal aging clock
eLife 12:e82364.
https://doi.org/10.7554/eLife.82364
Further reading
-
- Computational and Systems Biology
The force developed by actively lengthened muscle depends on different structures across different scales of lengthening. For small perturbations, the active response of muscle is well captured by a linear-time-invariant (LTI) system: a stiff spring in parallel with a light damper. The force response of muscle to longer stretches is better represented by a compliant spring that can fix its end when activated. Experimental work has shown that the stiffness and damping (impedance) of muscle in response to small perturbations is of fundamental importance to motor learning and mechanical stability, while the huge forces developed during long active stretches are critical for simulating and predicting injury. Outside of motor learning and injury, muscle is actively lengthened as a part of nearly all terrestrial locomotion. Despite the functional importance of impedance and active lengthening, no single muscle model has all these mechanical properties. In this work, we present the viscoelastic-crossbridge active-titin (VEXAT) model that can replicate the response of muscle to length changes great and small. To evaluate the VEXAT model, we compare its response to biological muscle by simulating experiments that measure the impedance of muscle, and the forces developed during long active stretches. In addition, we have also compared the responses of the VEXAT model to a popular Hill-type muscle model. The VEXAT model more accurately captures the impedance of biological muscle and its responses to long active stretches than a Hill-type model and can still reproduce the force-velocity and force-length relations of muscle. While the comparison between the VEXAT model and biological muscle is favorable, there are some phenomena that can be improved: the low frequency phase response of the model, and a mechanism to support passive force enhancement.
-
- Computational and Systems Biology
- Evolutionary Biology
There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.
